{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:32:00Z","timestamp":1760243520397,"version":"build-2065373602"},"reference-count":38,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2012,1,19]],"date-time":"2012-01-19T00:00:00Z","timestamp":1326931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Lethal toxin (LT) of Bacillus anthracis reduces the production of a number of inflammatory mediators, including transcription factors, chemokines and cytokines in various human cell lines, leading to down-regulation of the host inflammatory response. Previously we showed that the reduction of interleukin-8 (IL-8) is a sensitive marker of LT-mediated intoxication in human neutrophil-like NB-4 cells and that IL-8 levels are restored to normality when therapeutic monoclonal antibodies (mAb) with toxin-neutralising (TN) activity are added. We used this information to develop cell-based assays that examine the effects of TN therapeutic mAbs designed to treat LT intoxication and here we extend these findings. We present an in vitro assay based on human endothelial cell line HUVEC jr2, which measures the TN activity of therapeutic anti-LT mAbs using IL-8 as a marker for intoxication. HUVEC jr2 cells have the advantage over NB-4 cells that they are adherent, do not require a differentiation step and can be used in a microtitre plate format and therefore can facilitate high throughput analysis. This human cell-based assay provides a valid alternative to the mouse macrophage assay as it is a more biologically relevant model of the effects of toxin-neutralising antibodies in human infection.<\/jats:p>","DOI":"10.3390\/toxins4010028","type":"journal-article","created":{"date-parts":[[2012,1,19]],"date-time":"2012-01-19T11:56:08Z","timestamp":1326974168000},"page":"28-41","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of an in Vitro Potency Assay for Anti-anthrax Lethal Toxin Neutralizing Antibodies"],"prefix":"10.3390","volume":"4","author":[{"given":"Gail","family":"Whiting","sequence":"first","affiliation":[{"name":"Division of Bacteriology, National Institute of Biological Standards and Control, HPA, Blanche Lane, Potters Bar, Hertfordshire EN6 3QG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Baker","sequence":"additional","affiliation":[{"name":"Division of Bacteriology, National Institute of Biological Standards and Control, HPA, Blanche Lane, Potters Bar, Hertfordshire EN6 3QG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoerd","family":"Rijpkema","sequence":"additional","affiliation":[{"name":"Division of Bacteriology, National Institute of Biological Standards and Control, HPA, Blanche Lane, Potters Bar, Hertfordshire EN6 3QG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2012,1,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"Collier","year":"2003","journal-title":"Ann. Rev. Cell Dev. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mib.2003.12.001","article-title":"The roles of anthrax toxin in pathogenesis","volume":"7","author":"Moayeri","year":"2004","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1042\/bj20031382","article-title":"Anthrax lethal factor-cleavage products of MAPK (mitogen activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs","volume":"378","author":"Bardwell","year":"2004","journal-title":"Biochem. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"9402","DOI":"10.1074\/jbc.M211262200","article-title":"Anthrax lethal factor proteolysis and inactivation of MAPK kinase","volume":"278","author":"Chopra","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/nbt0908-981","article-title":"Cost\/success projections for US biodefense countermeasure development","volume":"26","author":"Matheny","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/toxins3081004","article-title":"Monoclonal antibody therapies against anthrax","volume":"3","author":"Chen","year":"2011","journal-title":"Toxins"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/IAI.00261-07","article-title":"Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax","volume":"75","author":"Albrecht","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1128\/IAI.00529-07","article-title":"In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity","volume":"75","author":"Staats","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/iai.61.1.245-252.1993","article-title":"Characterization of macrophage sensitivity and resistance to anthrax lethal toxin","volume":"61","author":"Friedlander","year":"1993","journal-title":"Infect. Immun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biologicals.2003.09.003","article-title":"Validation of the anthrax lethal toxin neutralization assay","volume":"32","author":"Hering","year":"2004","journal-title":"Biologicals"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0264-410X(01)00462-5","article-title":"Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans","volume":"20","author":"Pittman","year":"2002","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jim.2004.12.022","article-title":"Development of an edema factor-mediated cAMP-induction bioassay for detecting antibody-mediated neutralization of anthrax protective antigen","volume":"298","author":"Zmuda","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbrc.2008.07.018","article-title":"In vitro exposure to anthrax lethal toxin suppresses chemokine production in the human neutrophil-like cell line NB-4","volume":"374","author":"Barson","year":"2008","journal-title":"Biochem. Biophy. Res. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/prca.200700074","article-title":"Proteomic analysis of the response of the human neutrophil-like cell line NB-4 after exposure to anthrax lethal toxin","volume":"1","author":"Wheeler","year":"2007","journal-title":"Proteomics Clin. Appl."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1462-5822.2005.00606.x","article-title":"Inhibition of mitogen-activated protein kinase signaling by Bacillus anthracis lethal toxin causes destabilization of interleukin-8 mRNA","volume":"8","author":"Batty","year":"2006","journal-title":"Cell Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/432516","article-title":"Anthrax lethal toxin paralyzes neutrophil actin-based motility","volume":"192","author":"During","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1038\/sj.emboj.7601687","article-title":"Anthrax lethal toxin paralyzes actin-based motility by blocking Hsp27 phosphorylation","volume":"26","author":"During","year":"2007","journal-title":"EMBO J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.4049\/jimmunol.174.8.4966","article-title":"Anthrax lethal toxin blocks MAPK kinase-dependent IL-2 production in CD4 + T cells","volume":"174","author":"Fang","year":"2005","journal-title":"J. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-5793(02)03228-3","article-title":"Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells","volume":"527","author":"Popov","year":"2002","journal-title":"FEBS Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1462-5822.2010.01438.x","article-title":"Transcriptome dysregulation by anthrax lethal toxin plays a key role in induction of human endothelial cell cytotoxicity","volume":"12","author":"Rolando","year":"2010","journal-title":"Cell Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.4049\/jimmunol.179.5.3325","article-title":"Cytokine storm in the phase I trial of monoclonal antibody TGN1412: Better understanding the causes to improve preclinical testing of immunotherapeutics","volume":"179","author":"Stebbings","year":"2007","journal-title":"J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1290\/1543-706X(2003)039<0235:OONAHD>2.0.CO;2","article-title":"Optimization of NB-4 and HL-60 differentiation for use in opsonophagocytosis assays","volume":"39","author":"Fleck","year":"2003","journal-title":"In Vitro Cell Dev. Biol. Anim."},{"key":"ref_25","unstructured":"Combistats computer program for the statistical analysis of data from biological dilution assays or potency assays (EDQM).. Available online:http:\/\/combistats.edqm.eu\/."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/IAI.69.2.1175-1177.2001","article-title":"Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin","volume":"69","author":"Erwin","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.4049\/jimmunol.180.11.7516","article-title":"Anthrax lethal toxin enhances TNF-Induced endothelial VCAM-1 expression via an IFN regulatory factor-1-dependent mechanism","volume":"180","author":"Warfel","year":"2008","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0002-9440(10)63697-8","article-title":"Pathology and pathogenesis of bioterrorism-related inhalational anthrax","volume":"163","author":"Guarner","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1172\/JCI17991","article-title":"Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice","volume":"112","author":"Moayeri","year":"2003","journal-title":"J. Clin. Invest."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1084\/jem.20041215","article-title":"Anthrolysin O and other Gram-positive cytolysins are Toll-like receptor 4 agonists","volume":"200","author":"Park","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e2964","DOI":"10.1371\/journal.pone.0002964","article-title":"Anthrax toxins inhibit neutrophil signaling pathways in brain endothelium and contribute to the pathogenesis of meningitis","volume":"3","author":"Ebrahimi","year":"2008","journal-title":"PLoS One"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0002-9440(10)62496-0","article-title":"Anthrax lethal toxin induces endothelial barrier dysfunction","volume":"166","author":"Warfel","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.tcb.2006.09.008","article-title":"Actin\u2019 together: Serum response factor, its cofactors and the link to signal transduction","volume":"16","author":"Posern","year":"2006","journal-title":"Trends Cell. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.bbrc.2005.09.180","article-title":"Anthrax lethal toxin enhances cytokine-induced VCAM-1 expression on human endothelial cells","volume":"337","author":"Steele","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e1000359","DOI":"10.1371\/journal.ppat.1000359","article-title":"Anthrax lethal toxin impairs IL-8 expression in epithelial cells through Inhibition of histone H3 modification","volume":"5","author":"Raymond","year":"2009","journal-title":"PLoS Pathog."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1001222","DOI":"10.1371\/journal.ppat.1001222","article-title":"Inflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by Caspase-1, IL-1 signaling and neutrophil recruitment","volume":"6","author":"Moayeri","year":"2010","journal-title":"PLoS Pathog."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bbrc.2010.07.039","article-title":"Anthrax lethal toxin activates the inflammasome in sensitive rat macrophages","volume":"398","author":"Newman","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/IAI.00749-09","article-title":"The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes","volume":"77","author":"Nguyen","year":"2009","journal-title":"Infect. Immun."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/4\/1\/28\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:48:34Z","timestamp":1760219314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/4\/1\/28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,19]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1]]}},"alternative-id":["toxins4010028"],"URL":"https:\/\/doi.org\/10.3390\/toxins4010028","relation":{},"ISSN":["2072-6651"],"issn-type":[{"type":"electronic","value":"2072-6651"}],"subject":[],"published":{"date-parts":[[2012,1,19]]}}}